Glucagon Therapy
Glucagon Therapy is a medical intervention within antidote therapy that involves the administration of glucagon to counteract the effects of beta-blocker or calcium channel blocker toxicity by stimulating adenylate cyclase independently of beta-adrenergic receptors.
953
Publications
43.7K
Citations
3.7K
Authors
1K
Institutions
Publications per year
2017–2026
130
953
THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS
RogerH Unger, Lelio Orci · The Lancet · 1975 · 595 citations
Lazaros A. Nikolaidis, Dariush Elahi, Teresa Hentosz et al. · Circulation · 2004 · 512 citations · Full text
Medicine, Cardiology, Endocrinology +17
1–5 of 953
3.7K
24
h-index
The University of Texas Southwestern Medical Center, United States
14 publications · 1.3K citations
12
h-index
Indiana University – Purdue University Indianapolis, United States
14 publications · 535 citations
12
h-index
10
h-index
9
h-index
1–5 of 3.7K
1K
University of Copenhagen
Copenhagen, Denmark
24 h-index
152 publications
7.2K citations
Eli Lilly (United States)
Indianapolis, United States
21 h-index
95 publications
13K citations
Harvard University
Cambridge, United States
19 h-index
59 publications
3.3K citations
Yale University
New Haven, United States
17 h-index
57 publications
4.5K citations
Rigshospitalet
Copenhagen, Denmark
17 h-index
83 publications
2.9K citations
Indiana University – Purdue University Indianapolis
Indianapolis, United States
16 h-index
55 publications
3K citations
Oregon Health & Science University
Portland, United States
14 h-index
60 publications
2.8K citations
Indiana University School of Medicine
Indianapolis, United States
14 h-index
48 publications
2.5K citations
1–8 of 1K
JCEM · 44 publications · 2.5K citations
27
h-index
48 publications · 3.2K citations
27
h-index
30 publications · 3.3K citations
26
h-index
33 publications · 1.6K citations
24
h-index
Repository · 61 publications · 1.6K citations
23
h-index
1–5